Sublingual Buprenorphine/Naloxone and Multi-Modal Management for High-Risk Chronic Pain Patients

Sublingual Buprenorphine/Naloxone and Multi-Modal Management for High-Risk Chronic Pain Patients

Patients with chronic pain managed with opioid medications are at high risk for opioid overuse or misuse. West Virginia University (WVU) established a High-Risk Pain Clinic to use sublingual buprenorphine/naloxone (bup/nal) plus a multimodal approach to help chronic pain patients with history of Sub...

Full description

Bibliographic Details
Main Authors: Shane Kaski, Patrick Marshalek, Jeremy Herschler, Sijin Wen, Wanhong Zheng
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Journal of Clinical Medicine
Subjects:
buprenorphine
buprenorphine and naloxone (bup/nal)
opioid
pain
substance use disorder
Online Access:https://www.mdpi.com/2077-0383/10/5/973

Internet

https://www.mdpi.com/2077-0383/10/5/973

Similar Items